Medical Care
Global Vaccine Contract Manufacturing Market Research Report 2024
- Jan 20, 24
- ID: 20077
- Pages: 77
- Figures: 142
- Views: 23
The global Vaccine Contract Manufacturing market was valued at US$ 1731.5 million in 2023 and is anticipated to reach US$ 2558.5 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Contract Manufacturing.
Report Scope
The Vaccine Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Segment by Type
Fill-Finish
Bulk Product
Segment by Application
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Contract Manufacturing.
Report Scope
The Vaccine Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Segment by Type
Fill-Finish
Bulk Product
Segment by Application
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fill-Finish
1.2.3 Bulk Product
1.3 Market by Application
1.3.1 Global Vaccine Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Contract Manufacturing Market Perspective (2019-2030)
2.2 Vaccine Contract Manufacturing Growth Trends by Region
2.2.1 Global Vaccine Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Contract Manufacturing Market Dynamics
2.3.1 Vaccine Contract Manufacturing Industry Trends
2.3.2 Vaccine Contract Manufacturing Market Drivers
2.3.3 Vaccine Contract Manufacturing Market Challenges
2.3.4 Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2023
3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Vaccine Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Contract Manufacturing Market Size (2019-2030)
6.2 North America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size (2019-2030)
7.2 Europe Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Vaccine Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diosynth
11.1.1 Diosynth Company Detail
11.1.2 Diosynth Business Overview
11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.1.5 Diosynth Recent Development
11.2 Emergent BioSolutions
11.2.1 Emergent BioSolutions Company Detail
11.2.2 Emergent BioSolutions Business Overview
11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.2.5 Emergent BioSolutions Recent Development
11.3 Goodwin Biotechnology
11.3.1 Goodwin Biotechnology Company Detail
11.3.2 Goodwin Biotechnology Business Overview
11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.3.5 Goodwin Biotechnology Recent Development
11.4 Bavarian Nordic
11.4.1 Bavarian Nordic Company Detail
11.4.2 Bavarian Nordic Business Overview
11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.4.5 Bavarian Nordic Recent Development
11.5 Soligenix Inc
11.5.1 Soligenix Inc Company Detail
11.5.2 Soligenix Inc Business Overview
11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.5.5 Soligenix Inc Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Detail
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.6.5 Catalent Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fill-Finish
1.2.3 Bulk Product
1.3 Market by Application
1.3.1 Global Vaccine Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Contract Manufacturing Market Perspective (2019-2030)
2.2 Vaccine Contract Manufacturing Growth Trends by Region
2.2.1 Global Vaccine Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Contract Manufacturing Market Dynamics
2.3.1 Vaccine Contract Manufacturing Industry Trends
2.3.2 Vaccine Contract Manufacturing Market Drivers
2.3.3 Vaccine Contract Manufacturing Market Challenges
2.3.4 Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2023
3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Vaccine Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Contract Manufacturing Market Size (2019-2030)
6.2 North America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size (2019-2030)
7.2 Europe Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Vaccine Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diosynth
11.1.1 Diosynth Company Detail
11.1.2 Diosynth Business Overview
11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.1.5 Diosynth Recent Development
11.2 Emergent BioSolutions
11.2.1 Emergent BioSolutions Company Detail
11.2.2 Emergent BioSolutions Business Overview
11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.2.5 Emergent BioSolutions Recent Development
11.3 Goodwin Biotechnology
11.3.1 Goodwin Biotechnology Company Detail
11.3.2 Goodwin Biotechnology Business Overview
11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.3.5 Goodwin Biotechnology Recent Development
11.4 Bavarian Nordic
11.4.1 Bavarian Nordic Company Detail
11.4.2 Bavarian Nordic Business Overview
11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.4.5 Bavarian Nordic Recent Development
11.5 Soligenix Inc
11.5.1 Soligenix Inc Company Detail
11.5.2 Soligenix Inc Business Overview
11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.5.5 Soligenix Inc Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Detail
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.6.5 Catalent Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fill-Finish
Table 3. Key Players of Bulk Product
Table 4. Global Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Vaccine Contract Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Vaccine Contract Manufacturing Market Share by Region (2019-2024)
Table 8. Global Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Vaccine Contract Manufacturing Market Share by Region (2025-2030)
Table 10. Vaccine Contract Manufacturing Market Trends
Table 11. Vaccine Contract Manufacturing Market Drivers
Table 12. Vaccine Contract Manufacturing Market Challenges
Table 13. Vaccine Contract Manufacturing Market Restraints
Table 14. Global Vaccine Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Vaccine Contract Manufacturing Market Share by Players (2019-2024)
Table 16. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2023)
Table 17. Ranking of Global Top Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vaccine Contract Manufacturing Product Solution and Service
Table 21. Date of Enter into Vaccine Contract Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vaccine Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Vaccine Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2019-2024)
Table 29. Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2025-2030)
Table 31. North America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Vaccine Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Diosynth Company Detail
Table 47. Diosynth Business Overview
Table 48. Diosynth Vaccine Contract Manufacturing Product
Table 49. Diosynth Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 50. Diosynth Recent Development
Table 51. Emergent BioSolutions Company Detail
Table 52. Emergent BioSolutions Business Overview
Table 53. Emergent BioSolutions Vaccine Contract Manufacturing Product
Table 54. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 55. Emergent BioSolutions Recent Development
Table 56. Goodwin Biotechnology Company Detail
Table 57. Goodwin Biotechnology Business Overview
Table 58. Goodwin Biotechnology Vaccine Contract Manufacturing Product
Table 59. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 60. Goodwin Biotechnology Recent Development
Table 61. Bavarian Nordic Company Detail
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Vaccine Contract Manufacturing Product
Table 64. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Soligenix Inc Company Detail
Table 67. Soligenix Inc Business Overview
Table 68. Soligenix Inc Vaccine Contract Manufacturing Product
Table 69. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 70. Soligenix Inc Recent Development
Table 71. Catalent Biologics Company Detail
Table 72. Catalent Biologics Business Overview
Table 73. Catalent Biologics Vaccine Contract Manufacturing Product
Table 74. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 75. Catalent Biologics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Vaccine Contract Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Fill-Finish Features
Figure 4. Bulk Product Features
Figure 5. Global Vaccine Contract Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Vaccine Contract Manufacturing Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotech Companies Case Studies
Figure 9. Others Case Studies
Figure 10. Vaccine Contract Manufacturing Report Years Considered
Figure 11. Global Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Vaccine Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Vaccine Contract Manufacturing Market Share by Region: 2023 VS 2030
Figure 14. Global Vaccine Contract Manufacturing Market Share by Players in 2023
Figure 15. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2023
Figure 17. North America Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 19. United States Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 23. Germany Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Vaccine Contract Manufacturing Market Share by Region (2019-2030)
Figure 31. China Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 39. Mexico Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 43. Turkey Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 46. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 47. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 48. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 49. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 50. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fill-Finish
Table 3. Key Players of Bulk Product
Table 4. Global Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Vaccine Contract Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Vaccine Contract Manufacturing Market Share by Region (2019-2024)
Table 8. Global Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Vaccine Contract Manufacturing Market Share by Region (2025-2030)
Table 10. Vaccine Contract Manufacturing Market Trends
Table 11. Vaccine Contract Manufacturing Market Drivers
Table 12. Vaccine Contract Manufacturing Market Challenges
Table 13. Vaccine Contract Manufacturing Market Restraints
Table 14. Global Vaccine Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Vaccine Contract Manufacturing Market Share by Players (2019-2024)
Table 16. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2023)
Table 17. Ranking of Global Top Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vaccine Contract Manufacturing Product Solution and Service
Table 21. Date of Enter into Vaccine Contract Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vaccine Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Vaccine Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2019-2024)
Table 29. Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2025-2030)
Table 31. North America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Vaccine Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Diosynth Company Detail
Table 47. Diosynth Business Overview
Table 48. Diosynth Vaccine Contract Manufacturing Product
Table 49. Diosynth Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 50. Diosynth Recent Development
Table 51. Emergent BioSolutions Company Detail
Table 52. Emergent BioSolutions Business Overview
Table 53. Emergent BioSolutions Vaccine Contract Manufacturing Product
Table 54. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 55. Emergent BioSolutions Recent Development
Table 56. Goodwin Biotechnology Company Detail
Table 57. Goodwin Biotechnology Business Overview
Table 58. Goodwin Biotechnology Vaccine Contract Manufacturing Product
Table 59. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 60. Goodwin Biotechnology Recent Development
Table 61. Bavarian Nordic Company Detail
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Vaccine Contract Manufacturing Product
Table 64. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Soligenix Inc Company Detail
Table 67. Soligenix Inc Business Overview
Table 68. Soligenix Inc Vaccine Contract Manufacturing Product
Table 69. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 70. Soligenix Inc Recent Development
Table 71. Catalent Biologics Company Detail
Table 72. Catalent Biologics Business Overview
Table 73. Catalent Biologics Vaccine Contract Manufacturing Product
Table 74. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 75. Catalent Biologics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Vaccine Contract Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Fill-Finish Features
Figure 4. Bulk Product Features
Figure 5. Global Vaccine Contract Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Vaccine Contract Manufacturing Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotech Companies Case Studies
Figure 9. Others Case Studies
Figure 10. Vaccine Contract Manufacturing Report Years Considered
Figure 11. Global Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Vaccine Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Vaccine Contract Manufacturing Market Share by Region: 2023 VS 2030
Figure 14. Global Vaccine Contract Manufacturing Market Share by Players in 2023
Figure 15. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2023
Figure 17. North America Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 19. United States Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 23. Germany Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Vaccine Contract Manufacturing Market Share by Region (2019-2030)
Figure 31. China Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 39. Mexico Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Vaccine Contract Manufacturing Market Share by Country (2019-2030)
Figure 43. Turkey Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 46. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 47. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 48. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 49. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 50. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232